1School of Medicine, University of California San Diego, La Jolla, California. *Corresponding Author: James T. Robinson, School of Medicine, University of California ...

1Department of Oncology, University of Lausanne, Lausanne, Switzerland.

1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.

In 1978, a Cancer Research article by Dougherty and colleagues reported the first large-scale clinical trial of photodynamic therapy (PDT) for treatment of 113 cutaneous or subcutaneous lesions ...

1Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. Search for other works by this author on: 1Department of Clinical Pharmacology and ...

1Yonsei University, College of Medicine, Seoul, Republic of Korea.

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...

Cancer Res (2023) 83 (8_Supplement): LB215.

1Harpoon Therapeutics Inc., South San Francisco, CA.

1Department of Neurology, Meyer Cancer Center, Weill Cornell Medicine, New York, New York. *Corresponding Author: Howard A. Fine, Weill Cornell Medicine, 413 East ...

1Department of Biological Sciences, New York City College of Technology, City University of New York, Brooklyn, New York. 2Biology and Computer PhD Programs, The CUNY Graduate Center, City University ...

1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland. *Corresponding Author: Alison M. Mondul, Department of ...